Skip to content

Moderna MRNA Gross Profit

Gross Profit at other companies

Pfizer logo
PfizerPFE
$10.9B+0.3%
Novavax logo
NovavaxNVAX
$108.82M-83.3%
ALN
Alnylam PharmaceuticalsALNY
$959.66M+83.1%
Gilead Sciences logo
Gilead SciencesGILD
$5.52B+7.6%

Other financials

Income statement

See full
Revenue$389.0M+260%
Operating income-$1.4B-32.2%
Net income-$1.3B-38.3%
EPS (diluted)-$3.40-34.9%

Balance sheet

See full
Cash & equivalents$1.9B+17.4%
Total debt$1.3B+71.9%
Total equity$7.4B-26.4%
Total assets$11.5B-9.6%

Cash flow

See full
Operating cash flow-$630.0M+39.2%
CapEx$62.0M-47.0%
Free cash flow-$692.0M+40.0%

Valuation

See full
Market cap$27.09B+115%
Enterprise value$26.51B+120%
P/S12.2×+8.1×

Profitability

See full
Gross margin22.1%-32.0pp
Operating margin-153.3%+67.8pp
Net margin-143.6%+80.2pp
FCF margin-132.4%

Returns & leverage

See full
Return on equity-36.6%+11.9pp
Debt / equity0.2×+0.1×
Current ratio2.4×-1.8×

Where this comes from

Calculated from Moderna’s reported figures.

The official record: Moderna’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Moderna's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Moderna's gross profit?
Moderna (MRNA) reported gross profit of -$566M in Q1 2026.
How has Moderna's gross profit changed year-over-year?
Moderna's gross profit decreased by 3244.4% year-over-year, from $18M to -$566M.
What is the long-term trend for Moderna's gross profit?
Over 4 years (2021 to 2025), Moderna's gross profit has grown at a -49.0% compound annual growth rate (CAGR), from $15.85B to $1.08B.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.